I Cookies vengono usati per fornirti un servizio migliore. Proseguendo con la navigazione, acconsenti al loro utilizzo. Per negare il consenso o eliminarli dal tuo browser visita www.aboutcookies.org. Per maggiori informazioni leggi l'informativa.
Sustaining a good quality of life becomes harder as cancers progress. Advocates are saying their needs have gone unmet for too long, and are working with professionals to define what they need and how best to access it.
Managing common toxicities with new tyrosine kinase inhibitors
TKIs are involved in treating an increasing number of cancer indications. Doctors need to be aware of the range of potentially serious side effects associated with these drugs, and know how to mitigate them, to ensure that their patients get the greatest benefit.
Delivering the best possible quality of cancer care to every patient requires getting value for money from scarce resources. BBC journalist Matthew Hill earned himself a Best Cancer Reporter Award for taking a critical look at the cancer spending priorities in England.
As patents on the first generation of monoclonal antibodies begin to expire, the cancer community will need to get to grips with the unique issues involved in ensuring the safety and efficacy of copies of these complex drugs made by living cells.
As founding editor of Cancer World, Kathy Redmond set out to open up debate on the future of cancer care in Europe. She started a conversation that a full range of professionals and patient advocates have joined. We are still talking.